• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Invitae | Genelex

Invitae | Genelex

Pharmacogenetics Makes Precision Medicine Possible

  • For Patients
    • Conditions
    • Affected Drugs
    • What is PGx?
    • Resources
    • FAQs
  • For Providers
    • Conditions
    • Resources
    • Order Testing Supplies
  • Test Menu
  • Clinical Trials
  • About
    • Lab Accreditations
    • Genelex Team
    • Contact Us
  • Log In

Genelex: The Next Chapter

Home / News / Genelex: The Next Chapter

Genelex Blog

Genelex: The Next Chapter

After more than two decades of paternity testing, Genelex has sold its paternity testing division to DNA Diagnostics Center, allowing the company to respond to multiple years of 200%+ growth in pharmacogenetic testing and redouble its focus on the YouScript® Personalized Prescribing System.

Genelex was founded in 1987 and since then has been relied upon by state and international agencies for forensic and relationship testing to help solve complex cases and process immigration applications.

In 2000, Genelex became one of the first labs to provide pharmacogenetic (also known as pharmacogenomic) testing, and today the company’s high-capacity laboratory offers 9 pharmacogenetic tests and processes thousands of samples every month.

The company’s high accuracy results, clinical decision support tools and pharmacist support make it a recognized leader in pharmacogenetic testing and personalized medication management software.

Genelex Resources

Affected Conditions
Affected Drugs
Info for Providers
Frequently Asked Questions
Contact Genelex
Join Our Mailing List

Footer

CONTACT US

(800) 837-8362
info@genelex.com

3101 Western Ave.
Suite 100
Seattle, WA 98121

HELPFUL INFORMATION

What is PGx?
Test Menu
Conditions
Affected Drugs
FAQs
References

ABOUT GENELEX

Blog
News
Genelex Team
Lab Accreditations
Contact Us
Privacy Practices
Privacy Policy

  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube

KEEP IN TOUCH

Stay in the loop with news and updates from Genelex and be among the first to know when new tests become available.